BMY vs BOOM · P/E 17, rev $24.46B vs rev $292.5M
Bristol-Myers Squibb Company (BMY) versus Dmc Global Inc (BOOM) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Dmc Global Inc (BOOM) is a conglomerates company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported BOOM revenue for 2026-06-30 was $292.5M. Net income was -$5.6M. BOOM currently screens at market cap $141.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. BOOM currently screens at market cap $141.2M.
Not investment advice. Open the BMY and BOOM stock pages for the full models.
Not investment advice.